Navigation Links
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs
Date:6/18/2009

LIBERTYVILLE, Ill., June 18 /PRNewswire-USNewswire/ -- Families of Spinal Muscular Atrophy has just released details of the latest developments for the Families of SMA funded therapeutic pipeline.

Families of SMA is currently funding three distinct drug discovery programs: 1) Quinazolines to boost gene expression; 2) Tetracyclines at Paratek Pharmaceuticals to correct gene splicing; and 3) Motor neuron replacement program at California Stem Cell and UCI. These three programs represent an investment of over $16 Million so far to build a SMA drug pipeline.

Quinazoline Program:

In June 2009, the IND-enabling safety studies were completed for the FSMA-directed Quinazoline program. This is the program previously worked on by Vertex Pharmaceuticals and deCODE genetics, and fully funded by Families of SMA.

The next step for this program is to request a pre-IND meeting with the FDA and to prepare the required data package. Families of SMA will be working over the next several months with toxicology and regulatory experts to prepare for this meeting. According to Jill Jarecki, Ph.D., Research Director FSMA, "This meeting will be an exciting milestone for the project, and an essential step in the path towards human clinical trials of the drug candidate."

Motor Neuron Replacement Program:

California Stem Cell (CSC) is preparing for a final FDA pre-IND meeting to take place in mid 2009. This is a critical step on the track to submitting a formal Investigational New Drug (IND) application to the FDA to begin clinical trials in SMA Type I. It is the intent of CSC to gain approval to begin FDA-approved clinical trials for the use of these cells in development of a cell replacement therapy for SMA Type I.

Numerous pre-clinical efficacy studies have been completed, demonstrating that the cells work. The pivotal animal safety study, required to support an application to be
'/>"/>

SOURCE Families of Spinal Muscular Atrophy
Copyright©2009 PR Newswire.
All rights reserved

6

GOOD

Page: 1 2 3

Related medicine technology :

1. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
2. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
3. Helping Families Cope After an Injury
4. Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children
5. Actress and Mother Jennifer Garner Kicks Off American Lung Associations Faces of Influenza Awareness Campaign, Encouraging Families to Get Vaccinated Against Influenza
6. New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families
7. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
8. Congresswoman Supporting Spinal Cord Research Intended to Benefit U.S. Veterans
9. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
10. Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimers
11. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... TechTeam Global, Inc ., (Nasdaq: ... technology outsourcing and business process outsourcing services, announced ... director of global life sciences services. Roumans will ... ongoing capability enhancement in support of TechTeam,s life ... of experience in the life sciences industry, most ...
(Date:2/9/2010)... , February 9 Hoya Corporation ... December 31, 2009 .,Net sales were 106.8 billion ... 112.7,billion yen in the same period last ... 13.8% increase from 16.6 billion yen in ... orders and productivity. Compared to the second,quarter ended ...
(Date:2/9/2010)... , Feb. 9 Sanofi-aventis (EURONEXT: ... that it has successfully completed its tender offer for ... ( CHTT).   ,, The tender offer and withdrawal ... time, on February 8, 2010 .  The ... as of the expiration time, approximately 18,611,072 shares of ...
Breaking Medicine Technology:TechTeam Global Appoints Life Sciences Services Director 2TechTeam Global Appoints Life Sciences Services Director 3Hoya Announces Third Quarter Financial Results 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5How do we fund plant breeding 3F 10551 1How do we fund plant breeding 3F 10551 2How do we fund plant breeding 3F 10551 3Cranberries Provide Eight Hour Health Protection 60228 1Cranberries Provide Eight Hour Health Protection 60228 2Cranberries Provide Eight Hour Health Protection 60228 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 1Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 2Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 3Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 4Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL 28TM 29 DosePro 28TM 29 60223 5
(Date:2/9/2010)... research group of Dr. Franois Robert, a researcher at ... collaboration with the team of Dr. Daniel Durocher (Samuel ... technical breakthrough: they mapped all the fragile sites of ... . The method used by the researchers can be ... today in the scientific journal Nature Structural and ...
(Date:2/9/2010)... launched the nation,s first comprehensive research and training ... FBI has called "the crime of the 21st ... to food additives to auto parts- accounts for ... and has a major impact on health and ... Terrorist and other organized crime groups use proceeds ...
(Date:2/9/2010)... may be more effective in persuading young women to ... same issue, according to a new study. , Researchers ... about a teen pregnancy felt more vulnerable two weeks ... support for using birth control. , However, those who ... teen pregnancies were unmoved, and had no change in ...
(Date:2/9/2010)... Rockville, MD -- The first results from a ... Sub-Saharan African countries reveal that a high percentage ... substandard quality and thus may contribute to the ... , the most virulent form of malaria. The ... of Medicines (PQM) Program, a USAID-funded program implemented ...
(Date:2/9/2010)... YORK , Feb. 9 The ... Glover Blackwell : ,, "Reversing the childhood obesity epidemic ... Michelle Obama demonstrated today. ,, "As ... attend schools loaded with chips and soda -- and ... children, however, that bleak food landscape extends far beyond ...
Breaking Medicine News(10 mins):Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3
... of Bone and Mineral Research study by Indiana University-Purdue University ... fractures later in life. The study is now available in ... in a print edition in 2007. ,'Our ... of fractures later in life, and the old exercise adage ...
... to a International Labor Organization (ILO) report issued on Dec ... unable to work partially or fully due to// HIV and ... ILO added that the virus had a crippling effect on ... the virus has among children has threatened the future working ...
... Allergo Sorbent Test’ (RAST) machine, has been designed at ... the source allergen. ,An allergy is regarded ... it perceives as unsuitable. Hay fever, migraine, asthma, allergic ... the common allergic responses. ,At a press ...
... Scientists at Kings College, London have developed a new drug ... concept on which the drug is based on is that ... is prevented, thus sperms are not propelled out of the ... the control of schizophrenia and blood pressure, to which researchers ...
... implanted devices in their hearts face risks. The devices called ... allow an easy passage of// blood. It is inserted into ... that are coated with drugs are more liable to suffer ... times greater when compared to patients who use stents that ...
... with support from National Institute of Health and ... (ICMR), conducts// Sentinel Surveillance every year among high-risk ... the results of HIV prevalence in different population ... prevalence states where HIV prevalence among antenatal mothers ...
Other Medicine News:Health News:Exercise In Childhood Provides Lifelong Benefits 2Health News:ILO Reports On The Crippling Effects Of HIV On The Workforce 2Health News:Using Heart Stents Tends to Form More Clots 2
The second-generation Dade Behring Acute Care Troponin I (cTnI) method is the first FDA cleared high sensitivity cTnI assay with the low-end precision necessary to meet the ESC/ACC guidelines (CV <10...
... high-throughput immunoassay system built around the many ... the important addition of Logic Driven Incubation ... designed for optimal performance with the fastest ... assays such as the cardiac biomarkers and ...
AxSYM Myoglobin is a Microparticle Enzyme Immunoassay (MEIA) for the quantitative determination of myoglobin in human serum or plasma on the AxSYM System....
IRMA kit for detection of the cardiac marker Myoglobin...
Medicine Products: